Melanoma
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
Latest News
Novel analysis quantifies the benefit of melanoma screening
“Further studies are needed to determine whether individuals without a family history of melanoma may benefit from whole-body screening, and...
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
From the Journals
AI detects ugly-duckling skin lesions for melanoma follow-up
Using wide-field photos, a new artificial intelligence program can pick out lesions worthy of follow up for potential melanoma.
Clinical Insights
How has the pandemic affected rural and urban cancer patients?
From the Journals
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseases
A Dutch nationwide study in melanoma patients found relative safety of immune checkpoint inhibitors for grade 3 immune-related AEs but does not...
Conference Coverage
Neoadjuvant immunotherapy shows promise in stage III melanoma
There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.
Conference Coverage
Managing cancer outpatients during the pandemic: Tips from MSKCC
MSKCC has established guiding principles on how to manage cancer patients during the pandemic.
Guidelines
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
Conference Coverage
Expert offers tips for sorting out pink lesions on dermoscopy
“Always think about the lesion in context of the rest of the clinical picture and history,” Dr. Jennifer A. Stein advised.